• Skip to primary navigation
  • Skip to main content
Codagenix, Inc. logo
Menu
  • Approach
  • Pipeline
  • Team
  • Careers
  • News
  • Publications
  • Contact

Team Building the viral
platform of the future.

Leadership Team
Board of Directors
Investors & Partnerships
Scroll to
The Codagenix team and its founders pioneered the use of codon deoptimization to construct groundbreaking vaccines and virotheraputics. We are now pushing this proven method into the clinic and beyond.

Leadership team

J. Robert Coleman, PhD, MBA
Co-Founder, Chief Executive Officer
Steffen Mueller, PhD
Co-Founder, President & Chief Scientific Officer
Sybil Tasker, MD, MPH, FACP, FIDSA
Chief Medical Officer
Jeffrey Fu, PhD
Chief Business Officer
Tyler Cook
Chief Financial Officer
Johanna Kaufmann, PhD
Executive Vice President for Oncology
Bruce E. Taillon, PhD
Executive Vice President of Animal Health
Test tubes with abstract representation of DNA double helix and sequencing within.
We bring a wealth of experience in virology, computational science and patient care to developing a platform of viral therapeutics and vaccines capable of overcoming our biggest obstacles to global health.

Board of Directors

J. Robert Coleman, PhD, MBA
Co-Founder, Chief Executive Officer
Jill Howe
Chief Financial Officer, DTxPharma
Steffen Mueller, PhD
Co-Founder, President & Chief Scientific Officer
Charlie Petty
Co-Founder & Principal, Adjuvant Capital
Lori Rudolph-Owen, PhD
Chief Development Officer, Goldfinch Bio
Glenn Rockman
Founder and Managing Partner, Adjuvant Capital
Steven Winick
Managing Director, Topspin Partners

Investors & Partnerships

Work with us

Join our work in solving global health’s most pressing needs
Careers
Codagenix, Inc. logo
  • Approach
  • Pipeline
  • Team
  • Careers
  • News
  • Publications

Get in touch with us.

CONTACT US
Privacy Policy Terms & Conditions
© Codagenix 2022. All Rights Reserved.
Back to top